Arzneiwerk AG VIDA (FRA:TLIK)
Germany · Delayed Price · Currency is EUR 0.3900
-0.0080 (-2.01%)
At close: Jan 2, 2026
Arzneiwerk AG VIDA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 0.12 | 0.21 | 1.31 | 73.37 | 2.52 | 2.82 | Upgrade | |
Revenue Growth (YoY) | -99.57% | -84.20% | -98.21% | 2811.37% | -10.58% | -32.25% | Upgrade |
Cost of Revenue | -0 | 0 | 0.22 | 70.33 | 0.5 | 0.51 | Upgrade |
Gross Profit | 0.12 | 0.21 | 1.1 | 3.05 | 2.02 | 2.3 | Upgrade |
Selling, General & Admin | 0.13 | 0.17 | 1.22 | 2.8 | 1.48 | 1.63 | Upgrade |
Other Operating Expenses | 0.78 | 0.76 | 1.73 | 1.4 | 0.84 | 0.75 | Upgrade |
Operating Expenses | 0.92 | 0.94 | 2.96 | 20.74 | 2.34 | 2.4 | Upgrade |
Operating Income | -0.79 | -0.74 | -1.87 | -17.7 | -0.32 | -0.1 | Upgrade |
Interest Expense | -0.18 | -0.16 | -0.05 | -0.33 | -0 | -0.02 | Upgrade |
Interest & Investment Income | - | - | 0.01 | 0 | 0 | 0 | Upgrade |
Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | 0.01 | -0 | -0 | Upgrade |
Other Non Operating Income (Expenses) | 0.06 | 0.06 | 0.02 | 0 | 0.05 | - | Upgrade |
EBT Excluding Unusual Items | -0.92 | -0.84 | -1.89 | -18.02 | -0.27 | -0.11 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -0.01 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.03 | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 1 | Upgrade |
Pretax Income | -0.92 | -0.84 | -1.89 | -17.99 | -0.27 | 0.89 | Upgrade |
Income Tax Expense | -0 | - | -0 | -1.05 | 0 | 0.06 | Upgrade |
Earnings From Continuing Operations | -0.92 | -0.84 | -1.89 | -16.94 | -0.27 | 0.82 | Upgrade |
Earnings From Discontinued Operations | - | - | - | 0.31 | - | - | Upgrade |
Net Income | -0.92 | -0.84 | -1.89 | -16.64 | -0.27 | 0.82 | Upgrade |
Net Income to Common | -0.92 | -0.84 | -1.89 | -16.64 | -0.27 | 0.82 | Upgrade |
Net Income Growth | - | - | - | - | - | -78.70% | Upgrade |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 4 | Upgrade |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 4 | Upgrade |
Shares Change (YoY) | - | - | - | - | 42.65% | 50.00% | Upgrade |
EPS (Basic) | -0.15 | -0.13 | -0.30 | -2.67 | -0.04 | 0.19 | Upgrade |
EPS (Diluted) | -0.15 | -0.13 | -0.30 | -2.67 | -0.04 | 0.19 | Upgrade |
EPS Growth | - | - | - | - | - | -85.80% | Upgrade |
Free Cash Flow | -0.67 | -0.86 | -1.34 | -0.69 | -0.33 | -1 | Upgrade |
Free Cash Flow Per Share | -0.11 | -0.14 | -0.21 | -0.11 | -0.05 | -0.23 | Upgrade |
Gross Margin | 100.00% | 99.96% | 83.54% | 4.15% | 80.19% | 81.78% | Upgrade |
Operating Margin | -635.64% | -355.56% | -142.41% | -24.12% | -12.72% | -3.39% | Upgrade |
Profit Margin | -732.54% | -403.46% | -144.39% | -22.68% | -10.62% | 29.26% | Upgrade |
Free Cash Flow Margin | -539.49% | -412.96% | -101.92% | -0.94% | -13.11% | -35.47% | Upgrade |
EBITDA | -0.79 | -0.73 | -1.85 | -1.55 | -0.29 | -0.08 | Upgrade |
EBITDA Margin | - | - | -141.26% | -2.11% | -11.59% | -2.70% | Upgrade |
D&A For EBITDA | 0.01 | 0.01 | 0.02 | 16.15 | 0.03 | 0.02 | Upgrade |
EBIT | -0.79 | -0.74 | -1.87 | -17.7 | -0.32 | -0.1 | Upgrade |
EBIT Margin | - | - | -142.41% | -24.12% | -12.72% | -3.39% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 7.00% | Upgrade |
Revenue as Reported | 0.66 | 0.66 | 1.67 | - | - | 4.18 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.